SeaSpine Holdings (SPNE) Commences Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
SeaSpine Holdings (SPNE) Prices 6.8M Share Common Offering at $12.50/Sh
January 8, 2020 5:52 AM ESTSeaSpine Holdings Corporation (NASDAQ: SPNE) today announced the pricing of its previously announced underwritten public offering of 6,800,000 shares of its common stock at a public offering price of $12.50 per share. The gross proceeds to SeaSpine, before deducting the underwriting discounts and commissions and... More
SeaSpine Holdings (SPNE) reports prelim. Q4 results, expects full-year 2020 revenue to be in the range of $177 to $181 million
January 7, 2020 4:01 PM ESTSeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2019, with U.S Spinal Implants revenues expected to reflect growth within the 20% to 21% range.
We are pleased by our overall strong revenue performance in the fourth quarter and, in particular, the growth in excess of 20% in the U.S. Spinal Implants portfolio, said Keith Valentine, President and Chief Executive Officer. Based on the... More



